Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Immunotoxins: magic bullets or misguided missiles?

Vitetta ES, Thorpe PE, Uhr JW.

Immunol Today. 1993 Jun;14(6):252-9. Review. Erratum in: Immunol Today. 2008 Apr;29(4):149.

PMID:
8397766
2.

Immunotoxins: magic bullets or misguided missiles?

Vitetta ES, Thorpe PE, Uhr JW.

Trends Pharmacol Sci. 1993 May;14(5):148-54. Review.

PMID:
8212309
3.

Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.

Bodey B, Siegel SE, Kaiser HE.

Anticancer Res. 1996 Mar-Apr;16(2):661-74. Review.

PMID:
8687112
4.
5.

Therapeutic use of immunotoxins.

Cobb PW, LeMaistre CF.

Semin Hematol. 1992 Jul;29(3 Suppl 2):6-13. Review.

PMID:
1509295
6.

Overview of monoclonal antibodies in the diagnosis and therapy of cancer.

Vaickus L, Foon KA.

Cancer Invest. 1991;9(2):195-209. Review.

PMID:
1863875
7.

Recombinant immunotoxins in targeted cancer cell therapy.

Reiter Y.

Adv Cancer Res. 2001;81:93-124. Review.

PMID:
11430597
8.

Systemic immunotoxin therapy of cancer: advances and prospects.

Wawrzynczak EJ.

Br J Cancer. 1991 Oct;64(4):624-30. Review. No abstract available.

10.

Future prospects of monoclonal antibodies as magic bullets in immunotherapy.

Maleki LA, Baradaran B, Majidi J, Mohammadian M, Shahneh FZ.

Hum Antibodies. 2013;22(1-2):9-13. doi: 10.3233/HAB-130266. Review.

PMID:
24284304
11.

Rationale for clinical use of immunotoxins in cancer and autoimmune disease.

Byers VS, Baldwin RW.

Semin Cell Biol. 1991 Feb;2(1):59-70. Review.

PMID:
1954344
12.

Prospects for immunotoxin therapy of non-Hodgkin's lymphoma.

Grossbard ML, Fidias P.

Clin Immunol Immunopathol. 1995 Aug;76(2):107-14. Review.

PMID:
7614729
13.

Immunotoxin therapy of malignant melanoma.

Spitler LE.

Med Oncol Tumor Pharmacother. 1986;3(3-4):147-52. Review.

PMID:
3543527
14.

Humanized immunotoxins: a new generation of immunotoxins for targeted cancer therapy.

Mathew M, Verma RS.

Cancer Sci. 2009 Aug;100(8):1359-65. doi: 10.1111/j.1349-7006.2009.01192.x. Epub 2009 May 19. Review.

15.

Monoclonal antibodies in cancer immunotherapy.

Reisfeld RA.

Clin Lab Med. 1992 Jun;12(2):201-16. Review.

PMID:
1611818
16.

Targeted immunotherapy for colorectal cancer: monoclonal antibodies and immunotoxins.

Shapira S, Lisiansky V, Arber N, Kraus S.

Expert Opin Investig Drugs. 2010 Apr;19 Suppl 1:S67-77. doi: 10.1517/13543781003737668. Review.

PMID:
20374033
17.

Recombinant antibodies in cancer therapy.

Nayeem MS, Khan RH.

Curr Protein Pept Sci. 2006 Apr;7(2):165-70. Review.

PMID:
16611141
18.

Immunotoxins: new therapeutic reagents for autoimmunity, cancer, and AIDS.

Vitetta ES.

J Clin Immunol. 1990 Nov;10(6 Suppl):15S-18S. Review.

PMID:
2081785
19.

Enhanced therapeutic efficacy against an ovarian tumor xenograft of immunotoxins used in conjunction with recombinant alpha-interferon.

Pearson JW, Hedrick E, Fogler WE, Bull RL, Ferris DK, Riggs CW, Wiltrout RH, Sivam G, Morgan AC, Groves E, et al.

Cancer Res. 1990 Oct 1;50(19):6379-88.

20.

Immunotoxins against solid tumors.

Pirker R.

J Cancer Res Clin Oncol. 1988;114(4):385-93. Review.

PMID:
3045130

Supplemental Content

Support Center